There were significantdifferences in most clinical data and laboratory indicators between both groups,including APACHE II and SOFA scores, APACHE II death risk coefficient, levels ofleukocytes, hemoglobin, high-sensitivity C-reactive proteins, platelets, IL-6,FIB, D-dimer, albumin, globulin, γ-glutamyl transpeptidase, lactatedehydrogenase, total cholesterol, and blood lactic acid; percentage ofneutrophils; lymphocyte count; RDW; international normalized ratio; activatedpartial thromboplastin time; oxygenation index; length of hospital stay; hormonetreatment; and proportion of tumor diseases. This evidence concerns the gene IL6 and neoplasm.